Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]

Philippe Seguin, Bruno Laviolle, Patrick Guinet, Isabelle Morel, Yannick Mallédant, Eric Bellissant, Philippe Seguin, Bruno Laviolle, Patrick Guinet, Isabelle Morel, Yannick Mallédant, Eric Bellissant

Abstract

Introduction: Microcirculatory blood flow, and notably gut perfusion, is important in the development of multiple organ failure in septic shock. We compared the effects of dopexamine and norepinephrine (noradrenaline) with those of epinephrine (adrenaline) on gastric mucosal blood flow (GMBF) in patients with septic shock. The effects of these drugs on oxidative stress were also assessed.

Methods: This was a prospective randomized study performed in a surgical intensive care unit among adults fulfilling usual criteria for septic shock. Systemic and pulmonary hemodynamics, GMBF (laser-Doppler) and malondialdehyde were assessed just before catecholamine infusion (T0), as soon as mean arterial pressure (MAP) reached 70 to 80 mmHg (T1), and 2 hours (T2) and 6 hours (T3) after T1. Drugs were titrated from 0.2 microg kg(-1) min(-1) with 0.2 microg kg(-1) min(-1) increments every 3 minutes for epinephrine and norepinephrine, and from 0.5 microg kg(-1) min(-1) with 0.5 microg kg(-1) min(-1) increments every 3 minutes for dopexamine.

Results: Twenty-two patients were included (10 receiving epinephrine, 12 receiving dopexamine-norepinephrine). There was no significant difference between groups on MAP at T0, T1, T2, and T3. Heart rate and cardiac output increased significantly more with epinephrine than with dopexamine-norepinephrine, whereas. GMBF increased significantly more with dopexamine-norepinephrine than with epinephrine between T1 and T3 (median values 106, 137, 133, and 165 versus 76, 91, 90, and 125 units of relative flux at T0, T1, T2 and T3, respectively). Malondialdehyde similarly increased in both groups between T1 and T3.

Conclusion: In septic shock, at doses that induced the same effect on MAP, dopexamine-norepinephrine enhanced GMBF more than epinephrine did. No difference was observed on oxidative stress.

Trial registration: ClinicalTrials.gov NCT00134212.

Figures

Figure 1
Figure 1
Algorithm of doses adaptation in the two groups. MAP, mean arterial pressure.
Figure 2
Figure 2
Evolution of gastric mucosal blood flow (GMBF) and ratio between GMBF and cardiac output. T0, just before catecholamine infusion; T1, as soon as mean arterial pressure reached 70 to 80 mmHg; T2, 2 hours after T1; T3, 6 hours after T1. Data are presented as boxplots. CO, cardiac output.
Figure 3
Figure 3
Evolution of arterial lactate and malondialdehyde concentrations. T0, just before catecholamine infusion; T1, as soon as mean arterial pressure reached 70 to 80 mmHg; T2, 2 hours after T1; T3, 6 hours after T1. Data are presented as boxplots.

References

    1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–150.
    1. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946–955.
    1. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32:1928–1948.
    1. Collins JL, Vodovotz Y, Yoneyama T, Hatakeyama K, Green AM, Billiar TR. Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes. Surgery. 2001;130:256–264.
    1. Koike K, Moore FA, Moore EE, Poggetti RS, Tuder RM, Banerjee A. Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res. 1992;52:656–662.
    1. Asfar P, De Backer D, Meier-Hellmann A, Radermacher P, Sakka SG. Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care. 2004;8:170–179.
    1. Jacinto SM, Chintala MS, Lokhandwala MF, Jandhyala BS. Efficacy and mechanisms of dopexamine in the prevention of ischemia-reperfusion induced organ damage: role of oxygen free radicals. Clin Exp Hypertens. 1997;19:181–190.
    1. Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med. 1999;27:893–900.
    1. Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Malledant Y. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther. 2002;71:381–388.
    1. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. In: Armstrong D, editor. Methods in Molecular Biology: Free Radicals and Antioxidant Protocols. Totowa, NJ: Humana Press Inc; 1998. pp. 101–106.
    1. Bollaert PE, Bauer P, Audibert G, Lambert H, Larcan A. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest. 1990;98:949–953.
    1. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med. 1997;23:282–287.
    1. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med. 1997;25:399–404.
    1. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005;365:871–875.
    1. Meier-Hellmann A, Bredle DL, Specht M, Hannemann L, Reinhart K. Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Crit Care Med. 1999;27:2166–2171.
    1. Kiefer P, Tugtekin I, Wiedeck H, Bracht H, Geldner G, Georgieff M, Radermacher P. Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock. Am J Respir Crit Care Med. 2000;161:775–779.
    1. Temmesfeld-Wollbruck B, Szalay A, Mayer K, Olschewski H, Seeger W, Grimminger F. Abnormalities of gastric mucosal oxygenation in septic shock: partial responsiveness to dopexamine. Am J Respir Crit Care Med. 1998;157:1586–1592.
    1. Smithies M, Yee TH, Jackson L, Beale R, Bihari D. Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med. 1994;22:789–795.
    1. Levy B, Nace L, Bollaert PE, Dousset B, Mallie JP, Larcan A. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock. Intensive Care Med. 1999;25:942–948.
    1. Schmidt H, Secchi A, Wellmann R, Bach A, Bhrer H, Martin E. Dopexamine maintains intestinal villus blood flow during endotoxemia in rats. Crit Care Med. 1996;24:1233–1237.
    1. Madorin WS, Martin CM, Sibbald WJ. Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis. Crit Care Med. 1999;27:394–400.
    1. Tenhunen JJ, Uusaro A, Karja V, Oksala N, Jakob SM, Ruokonen E. Apparent heterogeneity of regional blood flow and metabolic changes within splanchnic tissues during experimental endotoxin shock. Anesth Analg. 2003;97:555–563.
    1. Hiltebrand LB, Krejci V, Banic A, Erni D, Wheatley AM, Sigurdsson GH. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med. 2000;28:3233–3241.
    1. Goode HF, Webster NR. Free radicals and antioxidants in sepsis. Crit Care Med. 1993;21:1770–1776.
    1. Cadenas S, Cadenas AM. Fighting the stranger – antioxidant protection against endotoxin toxicity. Toxicology. 2002;180:45–63.
    1. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med. 2003;31:1048–1052.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit